New selective PAD4 inhibitors binding a calcium-deficient method of the PAD4 enzyme have validated the important enzymatic purpose of human and mouse PAD4 in both equally histone citrullination and neutrophil extracellular lure development for, to our knowledge, the first time. The therapeutic potential of PAD4 inhibitors can now be explored. https://berniev111kxi4.bloggactif.com/profile